MRVI — Maravai Lifesciences Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $2.18bn
- $2.54bn
- $288.95m
- 78
- 21
- 64
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 24.7 | 236 | 551 | 632 | 575 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18.8 | 51.2 | 118 | 147 | 55.7 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 60.6 | 332 | 740 | 848 | 700 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 94.3 | 101 | 95.4 | 117 | 223 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 578 | 1,271 | 1,918 | 2,282 | 1,487 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 29.6 | 131 | 93.8 | 110 | 87.5 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 436 | 1,182 | 1,603 | 1,737 | 1,071 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 141 | 88.5 | 315 | 545 | 417 |
Total Liabilities & Shareholders' Equity | 578 | 1,271 | 1,918 | 2,282 | 1,487 |
Total Common Shares Outstanding |